Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But they already spend more on stock buybacks and dividends.

3 Dirt Cheap Stocks to Buy in January

11:15am, Saturday, 14'th Jan 2023 The Motley Fool
Bargains can easily be found as the new year gets underway.

3 Dirt Cheap Stocks to Buy in January

06:15am, Saturday, 14'th Jan 2023
Bargains can easily be found as the new year gets underway.
The CDC said one of its monitoring systems detected a preliminary safety signal for stroke in people ages 65 and older who received the Pfizer omicron booster.
XBB.1.5 has been dominant in the Northeast for several weeks and is now dominant in the U.S. as a whole.

Deciphera (DCPH) Rises 70% in the Past 6 Months: Here's Why

03:15pm, Friday, 13'th Jan 2023 Zacks Investment Research
Deciphera's (DCPH) Qinlock, approved for treating advanced gastrointestinal stromal tumors, has seen strong uptake since its approval. The recent restructuring initiative is saving costs.

Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

11:20am, Friday, 13'th Jan 2023 Zacks Investment Research
Style Box ETF report for SCHD
The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday. The post How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer,

High Yield Stock Watchlist - January 2023

08:46am, Friday, 13'th Jan 2023
There are 15 stocks on my high yield watchlist for January 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.
We believe that pharmaceutical giants Merck stock (NYSE: MRK) and Pfizer stock (NYSE: PFE) will likely offer similar returns over the next three years.
The COVID-19 pandemic made Pfizer the most recognizable pharmaceutical company on the planet. But, COVID policies are dialing back and the future demand for COVID products is not clear. The Street exp
PFE has dropped on concerns about post-COVID growth prospects. The company has an aggressive rollout plan for new products.
Reuters StanChart Weighed Sale Of $4B Aircraft Leasing Division As Macro Headwinds Weigh Standard Chartered PLC (OTC: SCBFY) eyed strategic options for its $3.7 billion aviation unit, including a sa
Is Pfizer stock a buy or a sell after getting a downgrade on its falling Covid-tied sales? Is PFE stock a buy or a sell right now?

3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off

12:50pm, Wednesday, 11'th Jan 2023 The Motley Fool
These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE